Cervical Fusion Market Research Report – forecast till 2030

$4,950$7,250

The cervical Fusion Market is registering a CAGR of 4.72% during the forecast period.

SKU: MRFR220383 Category:

Description

Cervical Fusion Market Research Report – forecast till 2030

Market Overview

The cervical Fusion Market is registering a CAGR of 4.72% during the forecast period. Cervical spinal fusion, otherwise called arthrodesis, is a surgery to associate bones in the cervical vertebral section of the spine underneath the neck. In the clinical areas, there are various techniques for performing cervical spinal fusion surgery wherein the most dominating is embedding a bone join for normal regrowth of the bone. Other than that, the utilization of fake units, for example, metal unions or polymer joins is likewise a substantial strategy utilized. These engineered embed joins are likewise used to keep the vertebrae intact until the development of another bone happens between them.
In view of our exploration, we have distinguished that the full-scale factors that are driving the worldwide market are the rising recurrence of cervical spondylosis among corporate specialists and the rising events of cervical wounds in vehicle mishaps. Further, the presentation of biomaterial cervical fusion inserts is another element driving the development of the cervical fusion market. In any case, then again, stresses over post-careful medicines are filling in as a smothering component for industry development. Coordinated efforts between enormous organizations and local players, then again, help the market’s allure.

Market Segment Overview

Based on Fusion Type the Global Cervical Fusion Market is classified into Anterior Interbody Fusion, Anterior Cervical Fusion, Posterior Fusion, and Others.
Based on the type segment the market is divided into Metal, Polymer, and Others.
The Surgery segment is bifurcated into Minimally Invasive Spine Surgery and Open Spine Surgery. The End User segment divides the market into Orthopedic Clinics, Multispecialty Hospitals, Neurology Clinics, and Others.

Regional Analysis

North America represented USD 882.93 million in 2021 and is supposed to show a 5.06% CAGR during the review time frame. This is credited to the developing rate of spine irregularities like scoliosis, kyphosis, and lordosis, as well as a maturing populace across the area.
Europe represents the second-biggest piece of the pie because of the accessibility of state-of-the-art treatment offices, government backing for the development of the medical services industry, a maturing populace, and an expansion in the occurrence of degenerative circle illness, rheumatoid joint pain, and osteoarthritis.
The Asia-Pacific Cervical Fusion Market is supposed to develop at a CAGR of 19.97% from 2022 to 2030. This is because of expanded paces of osteoarthritis and degenerative plate illness, the quickly developing clinical travel industry, and rising medical care costs
For example, India is inclined toward objective for clinical voyagers because of the accessibility of specialists, state-of-the-art innovation, and practical medicines.

Major Players

The key companies operating in the Cervical Fusion market are Medtronic Inc (Ireland), Abbott Laboratories (US), Stryker Corporation (US), DePuy Synthes (US), Braun Melsungen AG (Germany), NuVasive, Inc (US), Zimmer Biomet (US), Orthofix (US), and Globus Medical (US).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.
Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISING PREVALENCE OF CERVICAL SPONDYLOSIS IN CORPORATE PROFESSIONALS

4.2.2 GROWING CASES OF CERVICAL INJURIES IN AUTOMOBILE CRASHES

4.3 RESTRAINT

4.3.1 CONCERNS PERTAINING TO THE POST-SURGICAL PROCEDURES

4.4 OPPORTUNITY

4.4.1 EMERGENCE OF BIOMATERIAL CERVICAL FUSION IMPLANTS

5 MARKET FACTOR ANALYSIS

5.1 SUPPLY CHAIN ANALYSIS

5.1.1 R&D AND DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

6 GLOBAL CERVICAL FUSION MARKET, BY FUSION TYPE

6.1 OVERVIEW

6.2 ANTERIOR INTERBODY FUSION

6.3 ANTERIOR CERVICAL FUSION

6.4 POSTERIOR FUSION

7 GLOBAL CERVICAL FUSION MARKET, BY TYPE

7.1 OVERVIEW

7.2 METAL

7.3 POLYMER

7.4 OTHERS

8 GLOBAL CERVICAL FUSION MARKET, BY SURGERY

8.1 OVERVIEW

8.2 MINIMALLY INVASIVE SPINE SURGERY

8.3 OPEN SPINE SURGERY

9 GLOBAL CERVICAL FUSION MARKET, BY END USERS

9.1 OVERVIEW

9.2 ORTHOPAEDIC CLINICS

9.3 MULTISPECIALTY HOSPITALS

9.4 NEUROLOGY CLINICS

9.5 OTHERS

10 GLOBAL CERVICAL FUSION MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 FRANCE

10.3.3 UK

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 INDIA

10.4.3 JAPAN

10.4.4 AUSTRALIA

10.4.5 SOUTH KOREA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 MIDDLE EAST

10.5.2 AFRICA

10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 COMPETITIVE BENCHMARKING

11.3 MAJOR GROWTH STRATEGY IN CERVICAL FUSION MARKET

11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN CERVICAL FUSION MARKET

11.5 KEY DEVELOPMENT ANALYSIS

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES

11.6.2 PARTNERSHIP/COLLABORATION

11.6.3 BUSINESS EXPANSIONS/AGREEMENTS

11.6.4 MERGERS & ACQUISITIONS

11.7 MAJOR PLAYERS SALES ANALYSIS

11.7.1 SALES & OPERATING INCOME

11.8 MAJOR PLAYERS R&D ANALYSIS

12 COMPANY PROFILE

12.1 MEDTRONIC INC.

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 ABBOTT LABORATORIES

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 STRYKER CORPORATION

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 DEPUY SYNTHES

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 B. BRAUN MELSUNGEN AG

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS/SERVICES OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 NUVASIVE, INC.

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL ANALYSIS

12.6.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 KEY STRATEGIES

12.7 ZIMMER BIOMET

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 ORTHOFIX

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS/SERVICES/SOLUTIONS 0FFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 KEY STRATEGIES

12.9 GLOBUS MEDICAL

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS/SERVICES/SOLUTIONS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS

Companies Mentioned

Medtronic Inc (Ireland), Abbott Laboratories (US), Stryker Corporation (US), DePuy Synthes (US), Braun Melsungen AG (Germany), NuVasive, Inc (US), Zimmer Biomet (US), Orthofix (US), and Globus Medical (US).

Reviews

There are no reviews yet.

Be the first to review “Cervical Fusion Market Research Report – forecast till 2030”

[class^="wpforms-"]
[class^="wpforms-"]